This company has been marked as potentially delisted and may not be actively trading. Tenzing Acquisition (TZAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TZAC vs. COCP, CING, LPCN, MBRX, GOVX, PRPH, FLGC, EDSA, UBX, and MEIPShould you be buying Tenzing Acquisition stock or one of its competitors? The main competitors of Tenzing Acquisition include Cocrystal Pharma (COCP), Cingulate (CING), Lipocine (LPCN), Moleculin Biotech (MBRX), GeoVax Labs (GOVX), ProPhase Labs (PRPH), Flora Growth (FLGC), Edesa Biotech (EDSA), Unity Biotechnology (UBX), and MEI Pharma (MEIP). Tenzing Acquisition vs. Cocrystal Pharma Cingulate Lipocine Moleculin Biotech GeoVax Labs ProPhase Labs Flora Growth Edesa Biotech Unity Biotechnology MEI Pharma Cocrystal Pharma (NASDAQ:COCP) and Tenzing Acquisition (NASDAQ:TZAC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk. Is COCP or TZAC more profitable? Tenzing Acquisition's return on equity of -13.32% beat Cocrystal Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Cocrystal PharmaN/A -94.62% -78.24% Tenzing Acquisition N/A -13.32%-1.36% Do insiders & institutionals have more ownership in COCP or TZAC? 6.7% of Cocrystal Pharma shares are held by institutional investors. Comparatively, 60.9% of Tenzing Acquisition shares are held by institutional investors. 28.1% of Cocrystal Pharma shares are held by insiders. Comparatively, 37.5% of Tenzing Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, COCP or TZAC? Cocrystal Pharma has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Comparatively, Tenzing Acquisition has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Which has better earnings and valuation, COCP or TZAC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCocrystal PharmaN/AN/A-$17.98M-$1.57-0.98Tenzing AcquisitionN/AN/A$620KN/AN/A Do analysts prefer COCP or TZAC? Cocrystal Pharma presently has a consensus target price of $7.00, indicating a potential upside of 356.03%. Given Cocrystal Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Cocrystal Pharma is more favorable than Tenzing Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cocrystal Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tenzing Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer COCP or TZAC? Cocrystal Pharma received 24 more outperform votes than Tenzing Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformCocrystal PharmaOutperform Votes2477.42% Underperform Votes722.58% Tenzing AcquisitionN/AN/A Does the media refer more to COCP or TZAC? In the previous week, Cocrystal Pharma had 2 more articles in the media than Tenzing Acquisition. MarketBeat recorded 2 mentions for Cocrystal Pharma and 0 mentions for Tenzing Acquisition. Cocrystal Pharma's average media sentiment score of 1.33 beat Tenzing Acquisition's score of 0.00 indicating that Cocrystal Pharma is being referred to more favorably in the media. Company Overall Sentiment Cocrystal Pharma Positive Tenzing Acquisition Neutral SummaryCocrystal Pharma beats Tenzing Acquisition on 7 of the 12 factors compared between the two stocks. Get Tenzing Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TZAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TZAC vs. The Competition Export to ExcelMetricTenzing AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$5.07M$6.45B$2.53B$8.42BDividend YieldN/A2.64%13.04%4.10%P/E RatioN/A9.0411.3419.69Price / SalesN/A253.233,565,749.89118.34Price / Cash143.1065.8559.5734.62Price / Book1.016.403.544.50Net Income$620,000.00$143.98M-$428.08M$248.32M Tenzing Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TZACTenzing AcquisitionN/A$0.99-4.8%N/A-32.5%$5.07MN/A0.00N/AHigh Trading VolumeCOCPCocrystal Pharma3.1462 of 5 stars$1.54-1.3%$7.00+353.4%-24.7%$15.70MN/A-0.8310Positive NewsEarnings ReportAnalyst RevisionGap DownCINGCingulate2.3098 of 5 stars$3.91-1.8%$30.67+684.3%+301.2%$15.41MN/A-0.4620News CoverageAnalyst ForecastAnalyst RevisionGap UpLPCNLipocine1.5258 of 5 stars$2.87-1.7%$10.00+248.4%-44.6%$15.35M$11.20M-3.7810Gap UpMBRXMoleculin Biotech1.9585 of 5 stars$1.07-0.9%$6.00+460.7%-80.4%$14.98MN/A0.0020GOVXGeoVax Labs2.1593 of 5 stars$0.94+1.6%$11.10+1,080.9%-39.1%$14.28M$5.59M-0.2610PRPHProPhase Labs1.8889 of 5 stars$0.34+4.0%N/A-94.4%$14.24M$6.77M-0.27130News CoverageEarnings ReportGap UpFLGCFlora Growth2.4992 of 5 stars$0.73-3.0%$5.00+587.1%-47.5%$14.14M$59.51M-0.55280EDSAEdesa Biotech2.8447 of 5 stars$2.00+1.0%$21.00+950.0%-55.7%$14.05MN/A-1.0720Analyst RevisionGap DownUBXUnity Biotechnology3.6633 of 5 stars$0.81-10.2%$5.33+558.4%-49.5%$13.94M$240,000.00-0.6260Gap UpHigh Trading VolumeMEIPMEI Pharma2.1973 of 5 stars$2.09flatN/A-31.1%$13.92M$65.30M-0.36100Gap Down Related Companies and Tools Related Companies Cocrystal Pharma Competitors Cingulate Competitors Lipocine Competitors Moleculin Biotech Competitors GeoVax Labs Competitors ProPhase Labs Competitors Flora Growth Competitors Edesa Biotech Competitors Unity Biotechnology Competitors MEI Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TZAC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenzing Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenzing Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TZAC Stock Free TZAC Stock Alerts